Bangladesh Experience of Radiofrequency Ablation for Management of Hepatic Haemangioma

Authors

  • Sheikh Mohammad Noor E Alam Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Sheikh Mohammad Fazle Akbar Ehime University, Ehime, Japan, Oita University, Oita, Japan and Miyakawa Memorial Research Foundation, Tokyo, Japan
  • Musarrat Mahtab Department of Biochemistry, North North South University, Dhaka, Bangladesh
  • Taslima Akter Lima Farabi General Hospital, Dhaka, Bangladesh
  • Nirupoma Das Farabi General Hospital, Dhaka, Bangladesh
  • Nadia Binte Nasir Farabi General Hospital, Dhaka, Bangladesh
  • Nasif Shahriar Farabi General Hospital, Dhaka, Bangladesh
  • Md. Abdur Rahman Department of Anesthesia, Analgesia & Intensive Care Medicine, Holy Family Red Crescent Medical College, Dhaka, Bangladesh
  • Omar Faruque Sadman Department of Anesthesia, Square Hospital Limited, Dhaka, Bangladesh
  • Md. Abdur Rahim Department of Hepatology, International Medical College, Gazipur, Bangladesh
  • Ahmed Lutful Moben Kurmitola General Hospital, Dhaka, Bangladesh
  • Rokshana Begum Department of Hepatology, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh
  • Mamun Al Mahtab Interventional Hepatology Division, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

DOI:

https://doi.org/10.14738/bjhr.1203.18746

Abstract

Introduction: Hepatic haemangiomas are most common benign tumors of the liver. These are vascular malformations, which are usually asymptomatic. However, these may be potential cause of life-threatening complications at times. Methods: There are several treatment options for hepatic haemangiomas. Here we discuss radiofrequency ablation for management of this condition. Results: We included 15 patients with hepatic haemangiomas in this single arm, single Centre study. We ablated their haemangiomas with radiofrequency ablation. None had any major adverse event. At 6-month follow-up, the size of hepatic haemangioma was reduced in all patients. Conclusion: The study suggests radiofrequency ablation for management of hepatic haemangiomas is safe and effective.

References

Merrow AC, Gupta A, Patel MN, Adams DM. 2014 revised classification of vascular lesions from the International Society for the Study of Vascular Anomalies: radiologic-pathologic update. RadioGraphics 2016;36(5):1494–1516.

Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol 2012;47(2):106–117.

Danza FM, De Franco A, Marino V, Fasanelli L, Coscarella G, Rossi P, Bock E. Percutaneous sclerosis of giant cavernous hepatic hemangioma: preliminary report of two cases. In International Congress Series. Vol. 1230. Elsevier; 2001. p. 1083–7.

Ayoobi Yazdi N, Mehrabinejad M-M, Dashti H, Pourghorban R, Nassiri Toosi M, Rokni Yazdi H. Percutaneous sclerotherapy with bleomycin and ethiodized oil: a promising treatment in symptomatic giant liver hemangioma. Radiology. 2021;301(2):464–71.

Gao J, Fan RF, Yang JY, et al. Radiofrequency ablation for hepatic hemangiomas: a consensus from a Chinese panel of experts. World J Gastroenterol 2017;23(39):7077–7086.

Merrow AC, Gupta A, Patel MN, Adams DM. 2014 revised classification of vascular lesions from the international society for the study of vascular anomalies: radiologic-pathologic update. Radiographics. 2016;36(5):1494–516.

Dong W, Qiu B, Xu H, He L. Invasive management of symptomatic hepatic hemangioma. Eur J Gastroenterol Hepatol. 2019;31(9):1079–84.

Ayoobi Yazdi N, Dashti H, Batavani N, Borhani A, Shakiba M, Rokni Yazdi H. Percutaneous Sclerotherapy for Giant Symptomatic Liver Hemangiomas: A Pilot Study. J Vasc Interv Radiol. 2018 Feb;29(2):233-236. doi: 10.1016/j.jvir.2017.10.009. PMID: 29414196.

Liu X, Yang Z, Tan H, et al. Characteristics and operative treatment of extremely giant liver hemangioma >20 cm. Surgery 2017;161(6):1514–1524.

Gao J, Ding X, Ke S, Xin Z, Ning C, Sha Q, Sun W. Radiofrequency ablation in the treatment of large hepatic hemangiomas: a comparison of multitined and internally cooled electrodes. J Clin Gastroenterol 2014; 48: 540-547 [PMID:24926624 DOI: 10.1097/MCG.0b013e31829ef037]

Gao J, Kong J, Ding XM, Ke S, Niu HG, Xin ZH, Ning CM, Guo SG, Li XL, Zhang L, Dong YH, Sun WB. Laparoscopic vs computerized tomography-guided radiofrequency ablation for large hepatic hemangiomas abutting the diaphragm. World J Gastroenterol. 2015 May 21;21(19):5941-9. doi: 10.3748/wjg.v21.i19.5941. PMID: 26019459; PMCID: PMC4438029. 22

van Tilborg AAJM, Dresselaars HF, Scheffer HJ, Nielsen K, Sietses C, van den Tol PM, Meijerink MR. RF Ablation of Giant Hemangiomas Inducing Acute Renal Failure: A Report of Two Cases. Cardiovasc Intervent Radiol 2016; 39: 1644-1648 [PMID:27387187 DOI: 10.1007/s00270-016-1415-1]

Moben AL, Noor-E-Alam SM, Begum R, Rahim A, Sadman OF, Rahman MA, Shahriar N, Nasir NB, Das N, Lima TA, Mahmud T, Mahtab M, Akbar SMF, Mahtab MA. Percutaneous Sclerotherapy for Management of Large Hepatic Haemangioma: First Series from Bangladesh. British Journal of Healthcare and Medical Research 2025; 12(02), P-311-317. DOI:10.14738/bjhmr.1202.18613.

Cui Y, Zhou LY, Dong MK, Wang P, Ji M, Li XO, Chen CW, Liu ZP, Xu YJ, Zhang HW. Ultrasonography guided percutaneous radiofrequency ablation for hepatic cavernous hemangioma. World J Gastroenterol 2003; 9: 2132-2134 [PMID: 12970923 DOI:10.3748/wjg.v9.i9.2132]

Zagoria RJ, Roth TJ, Levine EA, Kavanagh PV. Radiofrequency ablation of a symptomatic hepatic cavernous hemangioma. AJR Am J Roentgenol 2004; 182: 210-212 [PMID: 14684541 DOI:10.2214/ajr.182.1.1820210]

Fan RF, Chai FL, He GX, Wei LX, Li RZ, Wan WX, Bai MD, Zhu WK, Cao ML, Li HM, Yan SZ. Laparoscopic radiofrequency ablation of hepatic cavernous hemangioma. A preliminary experience with 27 patients. Surg Endosc 2006; 20: 281-285 [PMID: 16362478 DOI: 10.1007/s00464-005-0184-8]

Zhang X, Yan L, Li B, Wen T, Wang W, Xu M, Wei Y, Yang J. Comparison of laparoscopic radiofrequency ablation versus open resection in the treatment of symptomatic-enlarging hepatic hemangiomas: a prospective study. Surg Endosc 2016; 30: 756-763 [PMID: 26123327 DOI: 10.1007/s00464-015-4274-y]

Gao J, Ke S, Ding XM, Zhou YM, Qian XJ, Sun WB. Radiofrequency ablation for large hepatic hemangiomas: initial experience and lessons. Surgery 2013; 153: 78-85 [PMID:22853860 DOI: 10.1016/j.surg.2012.06.004]

Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004;15(5):431–445.

Downloads

Published

2025-05-04

How to Cite

Noor E Alam, S. M., Akbar, S. M. F., Mahtab, M., Lima, T. A., Das, N., Nasir, N. B., … Al Mahtab, M. (2025). Bangladesh Experience of Radiofrequency Ablation for Management of Hepatic Haemangioma. British Journal of Healthcare and Medical Research, 12(03), 17–23. https://doi.org/10.14738/bjhr.1203.18746

Issue

Vol. 12 No. 03 (2025): British Journal of Healthcare and Medical Research

Section

Original Articles

License

Copyright (c) 2025 Sheikh Mohammad Noor E Alam, Rokshana Begum, Ahmed Lutful Moben, Md. Abdur Rahim, Omar Faruque Sadman, Md. Abdur Rahman, Nasif Shahriar, Nadia Binte Nasir, Nirupoma Das, Taslima Akter Lima, Musarrat Mahtab, Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)